Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

rhophilin-2 Activators

The chemical class known as rhophilin-2 activators encompasses a group of compounds that can influence the regulation of the actin cytoskeleton by modulating the signaling pathways rhophilin-2 is involved in. These activators can exert their influence by engaging with proteins and enzymes that control the dynamics of actin polymerization and depolymerization, which are critical for maintaining cellular structure and motility. By targeting various components of the Rho GTPase signaling pathways, these chemicals can alter the activity of rhophilin-2. For instance, interference with RhoA activity by specific inhibitors can trigger compensatory cellular responses that can activate rhophilin-2, aiming to balance the actin cytoskeletal changes induced by the inhibitor. Similarly, modulation of downstream effectors that are part of the RhoA signaling cascade can lead to adjustments in cellular tension and morphology, processes where rhophilin-2 has a regulatory role.

Besides direct modulation of Rho GTPases, these activators can bind to and inhibit regulators of actin filament stabilization and disassembly. By doing so, they can shift the dynamic equilibrium of actin filaments within the cell, which can activate rhophilin-2 as it responds to the altered cytoskeletal architecture. The actin cytoskeleton is also modulated by myosin ATPases and their associated kinases, and inhibitors of these proteins can result in changes to cell contractility and adhesion, which are other processes where rhophilin-2 is known to be a key player. Through this diverse range of targets, the activators can have a considerable impact on the functional state of rhophilin-2, enabling it to carry out its role in cytoskeletal organization and cell signaling. These chemicals are distinguished by their ability to engage with and modulate the biochemical pathways that influence rhophilin-2 activity, despite not interacting with the protein directly.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

A ROCK inhibitor that could possibly activate RHPN2 by influencing the actin cytoskeleton and cell motility, which are connected to RHPN2's regulatory functions in the RhoA pathway.

ML-7 hydrochloride

110448-33-4sc-200557
sc-200557A
10 mg
50 mg
$91.00
$267.00
13
(1)

Inhibits myosin light-chain kinase (MLCK), which could possibly activate RHPN2 by impacting actin dynamics and its mediated processes due to changes in actin cytoskeleton tension.

Jasplakinolide

102396-24-7sc-202191
sc-202191A
50 µg
100 µg
$184.00
$305.00
59
(1)

A cyclodepsipeptide that stabilizes actin filaments and could possibly activate RHPN2 by resulting in altered actin dynamics and its role in cytoskeletal regulation.

CK 666

442633-00-3sc-361151
sc-361151A
10 mg
50 mg
$321.00
$1040.00
5
(0)

An Arp2/3 complex inhibitor that could possibly activate RHPN2 by preventing actin polymerization, affecting its function in actin cytoskeleton remodeling.

Cytochalasin D

22144-77-0sc-201442
sc-201442A
1 mg
5 mg
$165.00
$486.00
64
(4)

Binds to the barbed ends of actin filaments and could possibly activate RHPN2 by preventing elongation and impacting its involvement in actin cytoskeleton maintenance.